P19-48. Induction of Ad5 neutralizing antibodies in placebo recipients during the Step Trial is not associated with risk of HIV infection

por Spies, G, Simandl, J, Casimiro, D, DeFawe, O, Noonan, L, Frahm, N, McElrath, MJ
Publicado 2009

P17-22. Impact of rare adenovirus seroprevalence on HIV-1 acquisition in the Step study

por Maxfield, LF, King, SL, Riggs, AM, Dilan, R, LaPorte, A, Hural, J, McElrath, MJ, Goudsmit, J, Barouch, DH
Publicado 2009

Vaccination with MVA/HIV induces differential recruitment of monocyte subsets into the circulation and monocyte-specific transcriptional programs

por Andersen-Nissen, E, Zak, DE, Hensley, TR, Adams, DJ, Hu, X, Sato, A, Elizaga, M, Goepfert, PA, Robinson, HL, Aderem, A, McElrath, MJ
Publicado 2012

OA06-06 LB. Evidence of vaccine-induced changes in breakthrough HIV-1 strains from the Step trial

por Rolland, M, Tovanabutra, S, Gilbert, PB, Sanders-Buell, E, Heath, L, deCamp, AC, Magaret, CC, Bose, M, Bradfield, A, O'Sullivan, A, Crossler, J, Deng, W, Zhao, H, Wong, K, Raugi, DN, Hural, J, Dubey, S, Frahm, N, Michael, NL, Shiver, J, Corey, L, Li, F, Self, SG, Kim, J, Buchbinder, S, Casimiro, DR, Robertson, MN, McElrath, MJ, McCutchan, FE, Mullins, JI
Publicado 2009

T-cell based sieve analysis ties HLA A*02 to vaccine efficacy and IgA-C1 immune correlate in RV144 Thai trial

por Hertz, T, Gartland, A, Janes, H, Li, S, Fong, Y, Tomaras, GD, Morris, D, Geraghty, D, Kijak, GH, Edlefsen, PT, Rolland, M, Larsen, BB, Tovanabutra, S, Sanders-Buell, E, DeCamp, AC, Magaret, CA, Ahmed, H, Nariya, S, Wong, K, Zhao, H, Deng, W, Maust, BS, Bose, M, Howell, S, Lazzaro, M, Bates, A, Lei, E, Bradfield, A, Ibitamuno, G, Assawadarachai, V, O'Connel, RJ, deSouza, MS, Nitayaphan, S, Rerks-Ngarm, S, Robb, ML, McElrath, MJ, Haynes, BF, Michael, NL, Gilbert, PB, Mullins, JI, Kim, JH
Publicado 2012